 |
Updated : Jun 2010
2010 Manuscripts and Chapters
- Burashnikov A, Antzelevitch C. Advances in the pharmacological treatment of atrial fibrillation.
Curr Med Lit Cardiol. 2010;29:1-5.
- Sicouri S, Carlsson L, Antzelevitch C. Electrophysiologic and antiarrhythmic effects of AZD1305 in canine pulmonary vein sleeves.
J Pharmacol Exp Ther. 2010;334:255-259
PMID:20360353
- Bloch Thomsen PE, Johannessen A, Jons C, Hansen TF, Kanters JK, Haarbo J, Hansen J, Christiansen LK, Sogaard P, Saermark K, Antzelevitch C. The role of local voltage potentials in outflow tract ectopy.
Europace. 2010;12:850-860.
PMID:20413613
- Viskin S, Postema PG, Bhuiyan ZA, Rosso R, Kalman JM, Vohra JK, Guevara-Valdivia ME, Marquez MF, Kogan E, Belhassen B, Glikson M, Strasberg B, Antzelevitch C, Wilde AAM. The response of the QT interval to the brief tachycardia provoked by standing: a bedside test for diagnosing long QT syndrome.
J Am Coll Cardiol. 2010;55:1955-1961.
PMID:20116193
- Sicouri S, Glass A, Ferreiro M, Antzelevitch C. Transseptal dispersion of repolarization and its role in the development of torsade de pointes arrhythmias.
J Cardiovasc Electrophysiol. 2010;21:441-447.
PMID:19909385
- Nof E, Cordeiro JM, Pérez GJ, Scornik FS, Calloe K, Love B, Burashnikov E, Caceres G, Gunsburg M, Antzelevitch C.A common single nucleotide polymorphism can exacerbate long QT type 2 syndrome leading to sudden infant death.
Circ Cardiovasc Genet. 2010;3:199-206.
PMID:20181576
- Sicouri S, Glass A, Ferreiro M, Antzelevitch C. Transseptal dispersion of repolarization and its role in the development of torsade de pointes arrhythmias.
J Cardiovasc Electrophysiol. 2010;21:441-447.
PMID:19909385
- Antzelevitch C, Yan GX. J wave syndromes.
Heart Rhythm. 2010;7:549-558
PMID:20153265
- Antzelevitch C. M cells in the human heart.
Circ Res. 2010;106:815-817
- Doss MX, Wagh V, Schulz H, Kull M, Kolde R, Pfannkuche K, Nolden T, Himmelbauer H, Vilo J, Hescheler J, Sachinidis A. Global transcriptomic analysis of murine embryonic stem cell-derived brachyury (T) cells.
Genes Cells. 2010;15:209-228.
PMID:20184659
- Nof E, Antzelevitch C, Glickson M. The contribution of HCN4 to normal sinus nose function in humans and animal models.
Pacing Clin Electrophysiol. 2010;33:100-106.
PMID:19796353
- Hu D, Barajas-Martinez H, Nesterenko VV, Pfeiffer R, Guerchicoff A, Cordeiro JM, Curtis AB, Pollevick GD, Wu Y, Burashnikov E, Antzelevitch C.Dual variation in SCN5A and CACNB2b underlies the development of cardiac conduction disease without Brugada syndrome.
Pacing Clin Electrophysiol. 2010;33:274-285.
PMID:20025708
- Chamberland C, Barajas-Martinez H, Haufe V, Fecteau MH, Delabre JF, Burashnikov A, Antzelevitch C, Lesur O, Chraibi A, Sarret P, Dumaine R. Modulation of canine cardiac sodium current by Apelin.
J Mol Cell Cardiol. 2010;48:694-701.
PMID:20036246
- Antzelevitch C, Burashnikov A. Atrial-selective sodium channel block as a novel strategy for the management of atrial fibrillation.
Ann N Y Acad Sci. 2010;1188:78-86.
PMID:20201889
- Burashnikov A, Antzelevitch C. New developments in atrial antiarrhythmic drug therapy.
Nat Rev Cardiol. 2010;7:139-48.
PMID:20179721
- Gunaseeli I, Doss MX, Antzelevitch C, Hescheler J, Sachinidis A. Induced pluripotent stem cells as a model for accelerated patient- and disease-specific drug discovery.
Curr Med Chem. 2010;17:759-766.
PMID:20088756
- Sicouri S, Burashnikov A, Belardinelli L, Antzelevitch C. Synergistic electrophysiologic and antiarrhythmic effects of the combination of ranolazine and chronic amiodarone in canine atria.
Circ Arrhythm Electrophysiol. 2010;3:88-95.
PMID:19952329
- Kapplinger JD, Tester DJ, Alders M, Benito B, Berthet M, Brugada J, Brugada P, Fressart V, Guerchicoff A, Harris-Kerr C, Kamakura S, Kyndt F, Koopmann TT, Miyamoto Y, Pfeiffer R, Pollevick GD, Probst V, Zumhagen S, Vatta M, Towbin JA, Shimizu W, Schulze-Bahr E, Antzelevitch C, Salisbury BA, Guicheney P, Wilde AA, Brugada R, Schott JJ, Ackerman MJ. An international compendium of mutations in the SCN5A-encoded cardiac sodium channel in patients referred for Brugada syndrome genetic testing.
Heart Rhythm. 2010;7:33-46.
PMID:20129283
- Wu J, Shimizu W, Ding WG, Ohno S, Toyoda F, Itoh H, Zang WJ, Miyamoto Y, Kamakura S, Matsuura H, Nademanee K, Brugada J, Brugada P, Brugada R, Vatta M, Towbin JA, Antzelevitch C, Horie M. KCNE2 modulation of Kv4.3 current and its potential role in fatal rhythm disorders.
Heart Rhythm. 2010;7:199-205.
PMID:20042375
- Nof E, Burashnikov A, Antzelevitch C. Cellular basis for atrial fibrillation in an experimental model of short QT1: Implications for a pharmacological approach to therapy. Heart Rhythm. 2010;7:251-257.
Heart Rhythm. 2010;7:251-257.
PMID:20042373
- Nam GB, Ko KH, Kim J, Park KM, Rhee KS, Choi KJ, Kim YH, Antzelevitch C. Mode of onset of ventricular fibrillation in patients with early repolarization pattern vs. Brugada syndrome.
Eur Heart J. 2010;31:330-339.
PMID:19880418
- Calloe K, Soltysinska E, Jespersen T, Lundby A, Antzelevitch C, Olesen SP, Cordeiro JM. Differential effects of the transient outward K+ current activator NS5806 in the canine left ventricle.
J Mol Cell Cardiol. 2010;48:191-200.
PMID:19632239
|
